just saw that Preethi Sundaram, the Chief Strategy Officer at Catalyst Pharmaceuticals, dumped about $103k worth of stock back in June. sold 3,924 shares when it was trading around $26 or so. honestly, insider sells don't always mean much - could be for tax reasons or just needing cash - but it's still worth paying attention to.

the company's been doing pretty solid financially though. their revenue growth was crushing it at like 43% over that quarter, and they've got a crazy high gross margin of 87%. the stock's trading at a P/E of 15.47 which isn't terrible compared to the sector average.

what's interesting is the stock dropped 2% after Sundaram's move. could be coincidence, could be something more. the company's working on some rare disease treatments which is a decent market, but yeah - when insiders start selling you gotta wonder what they know that we don't. anyone else watching CPRX or nah?